Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
Clinical trial NCT05721729 · COMPLETED
Trial details
- NCT number
- NCT05721729
- Sponsor
- Vogenx, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-23
- Primary completion
- 2024-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.